BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $841,000 | +97.4% | 51,735 | +68.2% | 0.03% | +100.0% |
Q4 2021 | $426,000 | -3.6% | 30,765 | 0.0% | 0.01% | -27.8% |
Q3 2021 | $442,000 | -32.6% | 30,765 | -25.9% | 0.02% | -33.3% |
Q2 2021 | $656,000 | +44.5% | 41,510 | -7.0% | 0.03% | +35.0% |
Q1 2021 | $454,000 | -2.2% | 44,620 | -28.4% | 0.02% | -4.8% |
Q4 2020 | $464,000 | +107.1% | 62,280 | -4.3% | 0.02% | +90.9% |
Q3 2020 | $224,000 | – | 65,090 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |